Drawing for ALTANØØV

USPTO serial 79273183

ALTANØØV

Reviewed by CopyMark Law Group

Reg. 6235790Status 700Renewal
Filing date
Status date
Registration date
Jan 5, 2021
Examiner
EISNACH,MICHAEL PATRICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ALTANØØV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*

Plus Government fees of $975

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dianne M. Smith-Misemer

Dianne M. Smith-Misemer Hovey Williams LLP10801 Mastin Boulevard, Suite 1000Overland Park, KS 66210UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical products and additives for use in industry, science as well as agriculture, horticulture and forestry particularly basic organic chemicals, chemical products for industrial fermentation, chemical products of biological origin, chemical bio-sourced products excluding fungicides, herbicides, insecticides and parasiticides; chemical products and additives other than for medical or veterinary use for the manufacture of polymers, cosmetics, perfumes, food flavorings, foodstuffs; unprocessed artificial resins; unprocessed polymer resins; unprocessed plastics; adhesives for use in industry; compost, manures, fertilizers; biological preparations for industrial and scientific use other than for medical or veterinary useACTIVE—
005Pharmaceutical products, medical and veterinary preparations, namely, for treating metabolic, hormonal, cutaneous, dermatological, endocrine, cardiovascular, pulmonary, ophthalmic, gastrointestinal, infectious, viral, genetic, neurological, cancerous, musculoskeletal, hepatological, respiratory, psychiatric and immune system related diseases, disorders and conditions; dietetic food and substances for medical and veterinary use; food supplements for humans and animals; food products in the nature of food supplements, dietetic foods enriched with nutritional elements for medical and veterinary use; products for destroying, namely, in particular vermin destroying preparations; fungicides, herbicidesACTIVE—
042Scientific and technological services, research and design services relating thereto, namely, scientific research; chemical and biochemical laboratory services; scientific research and engineering in the fields of chemistry, biology and biotechnology; chemical analysis; technical, scientific and technological research and development of products, from idea to industrial production, obtained by fermentation of microorganisms for use in the chemical, pharmaceutical, biotechnological industries and in the field of food for human and animal consumption, cosmetics and polymersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 5, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 2, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 9, 2021FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 9, 2021FIMPFINAL DISPOSITION PROCESSED—
Apr 5, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 14, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jan 25, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 5, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 20, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2020OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 30, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 14, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 11, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 11, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 9, 2020ALIEASSIGNED TO LIE—
Aug 30, 2020ALIEASSIGNED TO LIE—
Aug 10, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 28, 2020RFNTREFUSAL PROCESSED BY IB—
Feb 10, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 10, 2020RFRRREFUSAL PROCESSED BY MPU—
Jan 17, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 16, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 16, 2020DOCKASSIGNED TO EXAMINER—
Dec 10, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 6, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 5, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance